Cathie Wood’s ARK Invest is betting big on Recursion Pharmaceuticals (RXRX).
Recursion Pharmaceuticals (RXRX) is surging today on several catalysts, including the launch of its new AI assistant for drug discovery and Cathie Wood’s continued buying.
The company’s new AI assistant is designed to accelerate and improve the drug development process. It uses Recursion’s massive data set to generate insights that could lead to new drugs.
This technology could potentially lead to massive productivity and margin gains for companies using the tool.
Recursion also provides exposure to both the biotech and AI sectors, which is likely to attract more interest from investors like Cathie Wood.
Link to the original story: https://investorplace.com/2024/01/cathie-wood-is-betting-big-on-recursion-pharmaceuticals-rxrx-stock/
Three San Francisco supervisors receive threats following YC President Garry Tan’s tweet
E-commerce Delivery Innovations: Drones and Robotics
How Technology Is Making Construction More Efficient
About The Author
boB
Well, hey there! The name's boB, and I hail from the humble town of boBsville. I'm a bit of a jack-of-all-trades, you know? I enjoy tinkering around with gadgets, exploring the great outdoors, and meeting new people. If you have any questions or just want to chat, feel free to hit me up!